Literature DB >> 10468026

Gastropods as an evaluation tool for screening the irritating potency of absorption enhancers and drugs.

E Adriaens1, J P Remon.   

Abstract

PURPOSE: The objective of this study was to develop a simple alternative test using naked snails (slugs) for screening the irritating potency of chemicals on mucosal surfaces.
METHODS: The effect of various absorption enhancers and two beta-blocking agents on the mucosal tissue was determined from the total protein and lactate dehydrogenase released from the foot mucosa after treatment. Additionally, mucus production and reduction in body weight of the slugs caused by the treatment were measured.
RESULTS: According to the effects on the mucosal epithelium of the slugs the following rank order of increasing toxicity was established: PBS, HP-beta-CD (5%), beta-CD (1.8%) and oxprenolol hydrochloride (1%) < DDPC (1%) < STDHF (1%) < BAC (1%), SDC (1%) and propranolol hydrochloride (1%). The results of the present study are in agreement with other studies using the same compounds on other models.
CONCLUSIONS: The results of this study indicated the mucosa of slugs can serve as a primary screening tool for the evaluation of chemicals on mucosal surfaces. By simply measuring mucus production and weight loss reliable toxicity information can be obtained. This demonstrates rapid screening tests can be carried out using simple toxicity endpoints.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468026     DOI: 10.1023/a:1014801714590

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  The three Rs: the way forward: the report and recommendations of ECVAM Workshop 11.

Authors:  Michael Balls; Alan M Goldberg; Julia H Fentem; Caren L Broadhead; Rex L Burch; Michael F W Festing; John M Frazier; Coenraad F M Hendriksen; Margaret Jennings; Margot D O van der Kamp; David B Morton; Andrew N Rowan; Claire Russell; William M S Russell; Horst Spielmann; Martin L Stephens; William S Stokes; Donald W Straughan; James D Yager; Joanne Zurlo; Bert F M van Zutphen
Journal:  Altern Lab Anim       Date:  1995 Nov-Dec       Impact factor: 1.303

2.  Human buccal assay for evaluation of the mucosal irritation potential of drugs.

Authors:  V Place; P Darley; K Baricevic; A Ramans; B Pruitt; G Guittard
Journal:  Clin Pharmacol Ther       Date:  1988-03       Impact factor: 6.875

3.  Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity.

Authors:  E Marttin; J C Verhoef; S G Romeijn; F W Merkus
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

4.  Morphological correlate of regional partitioning of integumental water absorption in terrestrial slugs.

Authors:  D J Prior; T K Maugel; M Sellers
Journal:  Tissue Cell       Date:  1994-06       Impact factor: 2.466

5.  Influence of absorption enhancers (bile salts) and the preservative (benzalkonium chloride) on mucociliary function and permeation barrier function in rabbit tracheas.

Authors:  K Morimoto; Y Uehara; K Iwanaga; M Kakemi; Y Ohashi; A Tanaka; Y Nakai
Journal:  Eur J Pharm Sci       Date:  1998-07       Impact factor: 4.384

6.  Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line.

Authors:  P Saarinen-Savolainen; T Järvinen; K Araki-Sasaki; H Watanabe; A Urtti
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

7.  Assessment and validation of animal models to evaluate topical effects of substances on gastrointestinal mucosa.

Authors:  J W Fara; L D Anderson; A G Casper; R E Myrback
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

8.  The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study.

Authors:  R D Ennis; L Borden; W A Lee
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

9.  Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Authors:  Z Shao; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

10.  Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats.

Authors:  F W Merkus; J C Verhoef; S G Romeijn; N G Schipper
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

  10 in total
  6 in total

Review 1.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Using the Slug Mucosal Irritation Assay to Investigate the Tolerability of Tablet Excipients on Human Skin in the Context of the Use of a Nipple Shield Delivery System.

Authors:  Richard Kendall; Joke Lenoir; Stephen Gerrard; Rebekah L Scheuerle; Nigel K H Slater; Catherine Tuleu
Journal:  Pharm Res       Date:  2017-02-13       Impact factor: 4.200

3.  The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs.

Authors:  E Adriaens; K Dierckens; T G Bauters; H J Nelis; F van Goethem; P Vanparys; J P Remon
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

4.  Polyaphron Formulations Stabilised with Different Water-Soluble Polymers for Ocular Drug Delivery.

Authors:  Roman V Moiseev; Fraser Steele; Vitaliy V Khutoryanskiy
Journal:  Pharmaceutics       Date:  2022-04-24       Impact factor: 6.525

5.  Potential Mucosal Irritation Discrimination of Surface Disinfectants Employed against SARS-CoV-2 by Limacus flavus Slug Mucosal Irritation Assay.

Authors:  Marco Alfio Cutuli; Antonio Guarnieri; Laura Pietrangelo; Irene Magnifico; Noemi Venditti; Laura Recchia; Katia Mangano; Ferdinando Nicoletti; Roberto Di Marco; Giulio Petronio Petronio
Journal:  Biomedicines       Date:  2021-04-14

6.  Polyelectrolyte Multilayer Assemblies on Materials Surfaces: From Cell Adhesion to Tissue Engineering.

Authors:  Varvara Gribova; Rachel Auzely-Velty; Catherine Picart
Journal:  Chem Mater       Date:  2012-03-13       Impact factor: 9.811

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.